Skip to Main Content
print twitter facebook instagram blogger

Home | About | Surveys | Specialists | Forum | Professionals | Sitemap | Shop | Contact

Menopause news

Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?

5 October 2020

Cagnacci,a,* G. Bonaccorsi,b M. Gambacciani,c and the board of the Italian Menopause Society have provided advice on the use of hormone therapy during the Covid 19 pandemic.

On reviewing available evidence, they have concluded that while a recommendation for COVID-19-positive individuals to stop hormone therapy or oral contraceptives may seem wise, it is not based on real data. The concern about use of hormonal therapy in Covid-19 positive patients is based on the knowledge that some patients develop increased clotting, a risk which is associated with oral estrogens. However, the increased clotting effect of oral estrogens is due to increase in clotting (coagulation) factors produced by the liver. This effect for COVID-19 patients is likely the least important. In these individuals, increased coagulation is consequent to massive disturbance within blood vessels, with no evidence that an increase in coagulating factors plays any role. Since there is evidence that transdermal hormone replacement therapy does not increase clotting risk, it can be considered as required.


The group have suggested the following recommendations for COVID-19-infected women:

< Go Back

<< News Index

For your information...

Menopause + Premature Menopause + Menopause Symptoms + Bleeding Problems + Vaginal Problems + Bladder Matters Menopause and HRT after Hysterectomy Treatments + Diet, Lifestyle & Exercise + Menopause at Work Hormone Replacement Therapy + HRT Preparations + Prescribable non-HRT Testosterone Alternative Therapies + Alternative Techniques Decision Tree Contraception + Osteoporosis + Heart Disease + A to Z of menopause and medical conditions Magazine Shop More +